HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: OTC label reform

This article was originally published in The Rose Sheet

Executive Summary

OTC label reform: Department of Health and Human Services identifies label reform for over-the-counter drugs as a candidate for "consensual rulemaking" under the Clinton Administration's Reinventing Government initiative. OTC label reform was one of 19 candidates for consensual rulemaking compiled by FDA that appears in a recent HHS "summary report" on the department's regulatory reform efforts...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel